/content/dam/www/people-profile-photos/k/sita-kugel/sita-kugel-d.jpg
Kugel
Sita Kugel, PhD

Sita Kugel, PhD

  • Professor, Human Biology Division, Fred Hutch
  • Affiliate Investigator, Clinical Research Division, Fred Hutch
206.667.3648
Kugel Lab

Background

Dr. Sita Kugel studies pancreatic cancer, one of the most aggressive and deadly types of cancer. She works to understand the molecular changes that underpin different subtypes of pancreatic cancer and how these could be exploited to develop new targeted therapies. Dr. Kugel focuses on changes to DNA that affect how genes are turned on and off without altering the DNA sequence itself. She has developed several preclinical models of pancreatic cancer to test the consequences of these changes and potential therapies.

Education

PhD, Cancer Biology, Wayne State University School of Medicine, 2012

BSc, Kinesiology, Simon Fraser University, 2005

"Being able to make a meaningful impact on cancer as a disease — I think that is an amazing thing to be able to focus on each day."

— Dr. Sita Kugel

Find a Clinical Trial Led by Dr. Kugel

View Trials

Stories

All news
Pancreatic cancer experts, patients applaud new KRAS inhibitor therapy
Pancreatic cancer experts, patients applaud new KRAS inhibitor therapy Hope for patients and oncologists: ‘We’re at the beginning of a paradigm shift’ June 8, 2026
Two Fred Hutch studies identify pancreatic cancer biomarker driving basal disease
Two Fred Hutch studies identify pancreatic cancer biomarker driving basal disease Dr. Sita Kugel’s team recently published two papers identifying a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes apart, but reveals a biological mechanism that could lead to new therapies June 24, 2025
Priming the pump for future funding
Priming the pump for future funding Fred Hutch postdoctoral researchers win NIH training fellowship for pancreatic cancer and kinetochore projects September 4, 2024